Drug Profile


Alternative Names: MPC HSRC-Mission Pharmacal; MPC-SHRC; MPCHSRC

Latest Information Update: 03 May 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Mission Pharmacal
  • Class
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Urinary tract infections

Most Recent Events

  • 19 Apr 2017 Preclinical trials in Urinary tract infections in USA prior to April 2017 (PO)
  • 19 Apr 2017 Mission Pharmacal plans a phase II proof of concept trial for Urinary tract infections in USA (NCT03129295)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top